Table 3. Risk-adjusted life expectancy and years of life lost due to suboptimal HIV care stratified by gender and race/ethnicity.

Race/ethnicity	Gender	Life expectancy (years)		Years of life lost (vs. guideline-concordant)
		Guideline-concordant treatment	Actual treatment use in the HRN	Late ART initiation	Early ART discontinuation	Late ART initiation and Early ART discontinuation
Overall	Total	22.66	19.36	2.60	0.70	3.30
	Women	19.80	17.14	1.86	0.80	2.66
	Men	23.56	20.09	2.86	0.60	3.46
Black	Total	20.47	17.46	2.43	0.58	3.01
	Women	19.11	16.52	1.85	0.73	2.59
	Men	21.16	17.94	2.75	0.46	3.22
Hispanic	Total	24.08	20.18	3.06	0.85	3.90
	Women	22.63	18.87	2.30	1.46	3.76
	Men	24.48	20.57	3.27	0.64	3.91
White	Total	25.41	22.19	2.46	0.76	3.22
	Women	21.62	19.56	1.53	0.53	2.06
	Men	25.94	22.54	2.61	0.78	3.39

ART: antiretroviral therapy; HRN: HIV Research Network